4732 Stock Overview
Engages in the development of therapeutic drugs in Taiwan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
NatureWise Biotech & Medicals Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$25.25 |
| 52 Week High | NT$27.50 |
| 52 Week Low | NT$21.05 |
| Beta | 0.80 |
| 1 Month Change | 0.60% |
| 3 Month Change | -3.07% |
| 1 Year Change | -2.70% |
| 3 Year Change | -44.93% |
| 5 Year Change | 12.79% |
| Change since IPO | 46.50% |
Recent News & Updates
Recent updates
Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E
Apr 29
A Look At The Intrinsic Value Of NatureWise Biotech & Medicals Corporation (GTSM:4732)
Mar 25Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 20
Shareholder Returns
| 4732 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | -0.6% | -1.8% | -1.8% |
| 1Y | -2.7% | -21.7% | 27.9% |
Return vs Industry: 4732 exceeded the TW Personal Products industry which returned -21.7% over the past year.
Return vs Market: 4732 underperformed the TW Market which returned 27.9% over the past year.
Price Volatility
| 4732 volatility | |
|---|---|
| 4732 Average Weekly Movement | 4.9% |
| Personal Products Industry Average Movement | 4.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4732 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4732's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Zhong Yang Huang | www.naturewise.com.tw |
NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; PPL Taiwan green propolis; and NBM-BMX, an oral softgel capsule to treat cancer. The company was founded in 2000 and is based in Taipei, Taiwan.
NatureWise Biotech & Medicals Corporation Fundamentals Summary
| 4732 fundamental statistics | |
|---|---|
| Market cap | NT$1.24b |
| Earnings (TTM) | NT$15.76m |
| Revenue (TTM) | NT$224.58m |
78.8x
P/E Ratio5.5x
P/S RatioIs 4732 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4732 income statement (TTM) | |
|---|---|
| Revenue | NT$224.58m |
| Cost of Revenue | NT$101.23m |
| Gross Profit | NT$123.34m |
| Other Expenses | NT$107.58m |
| Earnings | NT$15.76m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.32 |
| Gross Margin | 54.92% |
| Net Profit Margin | 7.02% |
| Debt/Equity Ratio | 0% |
How did 4732 perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield63%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 21:37 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NatureWise Biotech & Medicals Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|